Literature DB >> 23135866

Clinical features and long-term renal outcomes of Japanese patients with obesity-related glomerulopathy.

Nobuo Tsuboi1, Kentaro Koike, Keita Hirano, Yasunori Utsunomiya, Tetsuya Kawamura, Tatsuo Hosoya.   

Abstract

BACKGROUND: Studies have suggested that obesity-related glomerulopathy (ORG) is one of the important disease entities leading to end-stage renal disease. However, information is limited regarding the clinical features and renal outcomes of Japanese ORG patients.
METHODS: Among the patients whose renal biopsy was performed at our institute during the past 10 years, we identified 28 ORG patients. Among them, the renal prognosis of the 20 patients with more than 2 years of follow-up was further analyzed. The clinical features at biopsy and the renal outcomes were compared with those of other ORG cohorts.
RESULTS: The average values at diagnosis were a body mass index of 32.0 kg/m(2), eGFR of 65 ml/min/1.73 m(2), and urinary protein excretion of 1.7 g/day. These features were less serious than those of the US cohort or the Spanish cohort and were compatible with those of the Chinese cohort. At the last observation, seven patients (35%) showed a 50% increase in their serum creatinine, and two patients (10%) had a 100% increase in serum creatinine and/or end-stage renal disease (end point). A multivariate analysis identified the time-averaged proteinuria during follow-up as an independent factor that was associated with the slope of renal function. The annual rate of patients reaching the end point in the US cohort, the Spanish cohort and the current cohort were 6.7, 6.9 and 1.6% per year, respectively.
CONCLUSION: The long-term outcomes of Japanese ORG patients include progression to renal failure, emphasizing the importance of an accurate early diagnosis of this entity.

Entities:  

Mesh:

Year:  2012        PMID: 23135866     DOI: 10.1007/s10157-012-0719-y

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  25 in total

1.  Marked association between obesity and glomerular hyperfiltration: a cross-sectional study in an African population.

Authors:  Grégoire Wuerzner; Menno Pruijm; Marc Maillard; Pascal Bovet; Claude Renaud; Michel Burnier; Murielle Bochud
Journal:  Am J Kidney Dis       Date:  2010-06-09       Impact factor: 8.860

2.  Body mass index and glomerular hyperfiltration in renal transplant recipients: cross-sectional analysis and long-term impact.

Authors:  R J Bosma; A J Kwakernaak; J J Homan van der Heide; P E de Jong; G J Navis
Journal:  Am J Transplant       Date:  2007-01-22       Impact factor: 8.086

3.  Glomerulomegaly and focal segmental glomerulosclerosis associated with obesity and sleep-apnea syndrome.

Authors:  J C Jennette; L Charles; W Grubb
Journal:  Am J Kidney Dis       Date:  1987-12       Impact factor: 8.860

4.  Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis.

Authors:  M Praga; E Hernández; E Morales; A P Campos; M A Valero; M A Martínez; M León
Journal:  Nephrol Dial Transplant       Date:  2001-09       Impact factor: 5.992

5.  Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy.

Authors:  M Praga; E Hernández; J C Herrero; E Morales; Y Revilla; R Díaz-González; J L Rodicio
Journal:  Kidney Int       Date:  2000-11       Impact factor: 10.612

6.  Remission of proteinuria improves prognosis in IgA nephropathy.

Authors:  Heather N Reich; Stéphan Troyanov; James W Scholey; Daniel C Cattran
Journal:  J Am Soc Nephrol       Date:  2007-10-31       Impact factor: 10.121

7.  Pathological influence of obesity on renal structural changes in chronic kidney disease.

Authors:  Shigeko Kato; Arifa Nazneen; Yumiko Nakashima; Mohammed S Razzaque; Tomoya Nishino; Akira Furusu; Noriaki Yorioka; Takashi Taguchi
Journal:  Clin Exp Nephrol       Date:  2009-04-29       Impact factor: 2.801

8.  Obesity-related glomerulopathy in China: a case series of 90 patients.

Authors:  Hui-Mei Chen; Shi-Jun Li; Hui-Ping Chen; Qing-Wen Wang; Lei-Shi Li; Zhi-Hong Liu
Journal:  Am J Kidney Dis       Date:  2008-04-18       Impact factor: 8.860

9.  The effects of weight loss on renal function in patients with severe obesity.

Authors:  Avry Chagnac; Tali Weinstein; Michal Herman; Judith Hirsh; Uzi Gafter; Yaacov Ori
Journal:  J Am Soc Nephrol       Date:  2003-06       Impact factor: 10.121

10.  Revised equations for estimated GFR from serum creatinine in Japan.

Authors:  Seiichi Matsuo; Enyu Imai; Masaru Horio; Yoshinari Yasuda; Kimio Tomita; Kosaku Nitta; Kunihiro Yamagata; Yasuhiko Tomino; Hitoshi Yokoyama; Akira Hishida
Journal:  Am J Kidney Dis       Date:  2009-04-01       Impact factor: 8.860

View more
  17 in total

Review 1.  Structural and Functional Changes in Human Kidneys with Healthy Aging.

Authors:  Musab S Hommos; Richard J Glassock; Andrew D Rule
Journal:  J Am Soc Nephrol       Date:  2017-08-08       Impact factor: 10.121

2.  Nephron hypertrophy and glomerulosclerosis and their association with kidney function and risk factors among living kidney donors.

Authors:  Hisham E Elsherbiny; Mariam P Alexander; Walter K Kremers; Walter D Park; Emilio D Poggio; Mikel Prieto; John C Lieske; Andrew D Rule
Journal:  Clin J Am Soc Nephrol       Date:  2014-10-15       Impact factor: 8.237

Review 3.  Obesity-related glomerulopathy: pathogenesis, pathologic, clinical characteristics and treatment.

Authors:  Tianhua Xu; Zitong Sheng; Li Yao
Journal:  Front Med       Date:  2017-08-08       Impact factor: 4.592

4.  Developmental cigarette smoke exposure II: Kidney proteome profile alterations in 6 month old adult offspring.

Authors:  Rachel E Neal; Rekha Jagadapillai; Jing Chen; Cynthia L Webb; Kendall Stocke; Cailtin Gambrell; Robert M Greene; M Michele Pisano
Journal:  Reprod Toxicol       Date:  2016-05-18       Impact factor: 3.143

Review 5.  Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis.

Authors:  Vivette D D'Agati; Avry Chagnac; Aiko P J de Vries; Moshe Levi; Esteban Porrini; Michal Herman-Edelstein; Manuel Praga
Journal:  Nat Rev Nephrol       Date:  2016-06-06       Impact factor: 28.314

Review 6.  The Renal Pathology of Obesity.

Authors:  Nobuo Tsuboi; Yusuke Okabayashi; Akira Shimizu; Takashi Yokoo
Journal:  Kidney Int Rep       Date:  2017-01-23

7.  Adiponectin protects obesity-related glomerulopathy by inhibiting ROS/NF-κB/NLRP3 inflammation pathway.

Authors:  Xiaohong Xu; Xiaolin Huang; Liexiang Zhang; Xiaoli Huang; Zihan Qin; Fei Hua
Journal:  BMC Nephrol       Date:  2021-06-10       Impact factor: 2.388

8.  Effects of Weight Loss Speed on Kidney Function Differ Depending on Body Mass Index in Nondiabetic Healthy People: A Prospective Cohort.

Authors:  Eiichiro Kanda; Toshitaka Muneyuki; Kaname Suwa; Kei Nakajima
Journal:  PLoS One       Date:  2015-11-23       Impact factor: 3.240

Review 9.  Weight Loss in Advanced Chronic Kidney Disease: Should We Consider Individualised, Qualitative, ad Libitum Diets? A Narrative Review and Case Study.

Authors:  Irene Capizzi; Luigi Teta; Federica Neve Vigotti; Giuliana Tognarelli; Valentina Consiglio; Stefania Scognamiglio; Giorgina Barbara Piccoli
Journal:  Nutrients       Date:  2017-10-11       Impact factor: 5.717

10.  Underweight Is an Independent Risk Factor for Renal Function Deterioration in Patients with IgA Nephropathy.

Authors:  Yan Ouyang; Jingyuan Xie; Meng Yang; Xiaoyan Zhang; Hong Ren; Weiming Wang; Nan Chen
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.